Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Novel Bispecific Degrader BHV-1310 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models including Nonhuman Primates

              Author:Nicholson, Simone   Dierks, Elizabeth   Kazmierski, Wes   Poole, Chuck   Dubowchik, Gene   Pirman, David   Spiegel, David   Bunin, Anna   Sharpe, Neal   Coric, Vlad   Car, Bruce   

              Session Name:S18: Paraneoplastic Neurological Disorders, irAE, Stiff Person, IGLON5  

              Topic:Autoimmune Neurology  

              Program Number:S18.009  

              Author Institution:Biohaven Pharmaceuticals, Inc. , New Haven, CT  Allucent, Cary, NC  Biohaven Pharmaceuticals, Inc. , Cambridge, MA  Yale University, New Haven, CT